Related references
Note: Only part of the references are listed.HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PIGF
Charlotte Rolny et al.
CANCER CELL (2011)
Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials
David Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pericytes and vessel maturation during tumor angiogenesis and metastasis
Ahmad Raza et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Double Antiangiogenic Protein, DAAP, Targeting VEGF-A and Angiopoietins in Tumor Angiogenesis, Metastasis, and Vascular Leakage
Young Jun Koh et al.
CANCER CELL (2010)
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev K. Shrimali et al.
CANCER RESEARCH (2010)
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
Sergio Rey et al.
CARDIOVASCULAR RESEARCH (2010)
PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
Carlos Bais et al.
CELL (2010)
Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
Sara Van de Veire et al.
CELL (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Angiopoietin-2 Interferes with Anti-VEGFR2-Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas
Sung-Suk Chae et al.
CLINICAL CANCER RESEARCH (2010)
Pathways mediating VEGF-independent tumor angiogenesis
Napoleone Ferrara
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse
Feng-Ju Huang et al.
DEVELOPMENTAL BIOLOGY (2010)
IMPROVED INTRATUMORAL OXYGENATION THROUGH VASCULAR NORMALIZATION INCREASES GLIOMA SENSITIVITY TO IONIZING RADIATION
Mackenzie C. McGee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tumor vessel biology in pediatric intracranial ependymoma Clinical article
Michiel Wagemakers et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2010)
Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation
Adrianne L. Myers et al.
JOURNAL OF PEDIATRIC SURGERY (2010)
Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery
Tina D. Tailor et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Real-time imaging reveals the single steps of brain metastasis formation
Yvonne Kienast et al.
NATURE MEDICINE (2010)
Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks
Walid S. Kamoun et al.
NATURE METHODS (2010)
In vivo wide-area cellular imaging by side-view endomicroscopy
Pilhan Kim et al.
NATURE METHODS (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Tumor Microvasculature and Microenvironment: Novel Insights Through Intravital Imaging in Pre-Clinical Models
Dai Fukumura et al.
MICROCIRCULATION (2010)
Plasma Soluble VEGFR-1 Is a Potential Dual Biomarker of Response and Toxicity for Bevacizumab with Chemoradiation in Locally Advanced Rectal Cancer
Dan G. Duda et al.
ONCOLOGIST (2010)
Heterogeneity of the Tumor Vasculature
Janice A. Nagy et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
The shunt problem: control of functional shunting in normal and tumour vasculature
Axel R. Pries et al.
NATURE REVIEWS CANCER (2010)
Targeting the tumour vasculature: insights from physiological angiogenesis
Alicia S. Chung et al.
NATURE REVIEWS CANCER (2010)
Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels
Beverly L. Falcon et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Molecular differentiation and specialization of vascular beds
Susana F. Rocha et al.
ANGIOGENESIS (2009)
Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
Konstantin Gaengel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Host-Derived Angiopoietin-2 Affects Early Stages of Tumor Development and Vessel Maturation but Is Dispensable for Later Stages of Tumor Growth
Patrick Nasarre et al.
CANCER RESEARCH (2009)
A Vascular Normalization Index as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
A. Gregory Sorensen et al.
CANCER RESEARCH (2009)
Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
Massimiliano Mazzone et al.
CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
VEGF inhibition: insights from preclinical and clinical studies
Yongping Crawford et al.
CELL AND TISSUE RESEARCH (2009)
Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer
Elise Langenkamp et al.
CELL AND TISSUE RESEARCH (2009)
Oxygen Sensors at the Crossroad of Metabolism
Julian Aragones et al.
CELL METABOLISM (2009)
Human Studies of Angiogenic Gene Therapy
Rajesh Gupta et al.
CIRCULATION RESEARCH (2009)
The tumor microenvironment and metastatic disease
Sarah Jane Lunt et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging
James P. B. O'Connor et al.
CLINICAL CANCER RESEARCH (2009)
The Extracellular Matrix of Blood Vessels
Johannes A. Eble et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Role of Placental Growth Factor in Mesenteric Neoangiogenesis in a Mouse Model of Portal Hypertension
Christophe Van Steenkiste et al.
GASTROENTEROLOGY (2009)
Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
Christopher G. Willett et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor-Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice
Walid S. Kamoun et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells
Katrien De Bock et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
Hellmut G. Augustin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
Scott R. Plotkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature
Eva-Maria Hedlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress
Mark W. Dewhirst
RADIATION RESEARCH (2009)
Interdependence of hypoxic and innate immune responses
Victor Nizet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Vascular changes in hepatocellular carcinoma
Zhen Fan Yang et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2008)
The role of endothelial-to-mesenchymal transition in cancer progression
S. Potenta et al.
BRITISH JOURNAL OF CANCER (2008)
Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment
M. E. Eichhorn et al.
CANCER BIOLOGY & THERAPY (2008)
Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide
Qingyu Zhou et al.
CLINICAL CANCER RESEARCH (2008)
Generation and characterization of rgs5 mutant mice
Maya H. Nisancioglu et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
Timothy P. Padera et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization
An Claes et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Juliana Hamzah et al.
NATURE (2008)
A role for VEGF as a negative regulator of pericyte function and vessel maturation
Joshua I. Greenberg et al.
NATURE (2008)
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
Christian Stockmann et al.
NATURE (2008)
Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts
Pipsa Saharinen et al.
NATURE CELL BIOLOGY (2008)
Perivascular nitric oxide gradients normalize tumor vasculature
Satoshi Kashiwagi et al.
NATURE MEDICINE (2008)
Response criteria for glioma
A. Gregory Sorensen et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Pericytes: gatekeepers in tumour cell metastasis?
Holger Gerhardt et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Christian Fischer et al.
NATURE REVIEWS CANCER (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer
Rakesh K. Jain
NATURE REVIEWS CANCER (2008)
Revacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy
Paxton V. Dickson et al.
CLINICAL CANCER RESEARCH (2007)
Hypoxia-driven selection of the metastatic phenotype
Richard Sullivan et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Benjamin J. Moeller et al.
CANCER AND METASTASIS REVIEWS (2007)
Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization
Ruud P. M. Dings et al.
CLINICAL CANCER RESEARCH (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization
Rakesh K. Jain et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis
J Hagendoorn et al.
CANCER RESEARCH (2006)
Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxia
M Franco et al.
CANCER RESEARCH (2006)
Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling
F Baffert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma
MG Ozawa et al.
CANCER (2005)
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal cancer patients
CG Willett et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis
RA Cardone et al.
NATURE REVIEWS CANCER (2005)
Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metal loproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants
S Vosseler et al.
CANCER RESEARCH (2005)
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume
GC Jayson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cellular abnormalities of blood vessels as targets in cancer
P Baluk et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients
Y Yonenaga et al.
ONCOLOGY (2005)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Abnormal vessel tortuosity as a marker of treatment response of malignant gliomas: Preliminary report
E Bullitt et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2004)
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors
RT Tong et al.
CANCER RESEARCH (2004)
Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors
P Baluk et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors
A Abramsson et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-II
H Wildiers et al.
BRITISH JOURNAL OF CANCER (2003)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
Tumor biology - Herceptin acts as an anti-angiogenic cocktail
Y Izumi et al.
NATURE (2002)
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
S Morikawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
P Carmeliet et al.
NATURE MEDICINE (2001)
Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
A Pettersson et al.
LABORATORY INVESTIGATION (2000)
Share Paper
